-
Study aim
-
The effect of fentanyl and dexmedetomidine as adjuvants on pain after cesarean section
-
Design
-
Clinical trial with control group, with parallel groups, double-blind, randomized, phase 3 is performed on 100 patients. Patients are randomly divided into two groups (by lottery method).
-
Settings and conduct
-
The location of this study is Valiasr hospital in Birjand city in 1401-1400. The severity of patients' pain will be evaluated according to VAS scoring by the intern. Intern and patients are blind.
-
Participants/Inclusion and exclusion criteria
-
Inclusion criteria: informed consent, ASA class 1 and 2, term pregnancy, non-emergency cesarean section. Exclusion criteria: drug addiction, dissatisfaction with spinal anesthesia, duration of surgery more than 1 hour, pregnancy with ASA 3 and above; patients with brain trauma, patients with spinal deformity; Inability to position the patient, spinal infection, hypersensitivity to local anesthetic drugs, high ICP and the presence of coagulation disorders and heart valve problems (especially AS).
-
Intervention groups
-
Patients in the control group under spinal anesthesia with marcaine 0.5% 2 cc (10 mg) + fentanyl 0.5 cc (25 micrograms) total 2.5 cc, and the intervention group marcaine 5% (10 mg) + dex duodenum diluted cc / 5 0 (5 micrograms) will be a total of 2.5 cc. The needle used is a Quinke gauge needle 25 gauge and the speed of drug injection in spinal anesthesia will be 0.2 cc / sec and anesthesia will be performed in a sitting position in L4 and L3. Patients' surgery will be performed by a surgeon. Patients' pain at intervals of 1, 2, 3, 4, 8 and 12 hours will be assessed by the audiologist using the visual-auditory assessment (VAS). Also, the time of the first request for analgesic drug by the patient.
-
Main outcome variables
-
Pain